Silo Pharma Inc
(SILO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 18 | 18 | 18 | 17 | 0 |
| Cost of Goods | 2 | 2 | 2 | 1 | N/A |
| Gross Profit | 17 | 17 | 17 | 17 | N/A |
| Operating Expenses | 960 | 482 | 455 | 918 | 484 |
| Operating Income | -942 | -464 | -437 | -901 | -487 |
| Other Income | -115 | 6,956 | 48 | 37 | -9 |
| Pre-tax Income | -1,057 | 6,492 | -389 | -864 | -496 |
| Income Tax | 6 | 19 | N/A | N/A | N/A |
| Net Income Continuous | -1,063 | 6,472 | -389 | -864 | -496 |
| Net Income Discontinuous | -26 | -87 | -73 | -67 | -294 |
| Net Income | $-1,089 | $6,385 | $-462 | $-931 | $-790 |
| EPS Basic Total Ops | -1.85 | 3.20 | 0.00 | -0.03 | 0.00 |
| EPS Basic Continuous Ops | -1.76 | 3.24 | 0.00 | -0.03 | 0.01 |
| EPS Basic Discontinuous Ops | -0.09 | -0.04 | 0.00 | 0.00 | -0.01 |
| EPS Diluted Total Ops | -1.81 | 3.16 | 0.00 | -0.03 | 0.00 |
| EPS Diluted Continuous Ops | -1.74 | 3.20 | 0.00 | -0.03 | 0.01 |
| EPS Diluted Discontinuous Ops | -0.09 | -0.04 | 0.00 | 0.00 | -0.01 |
| EBITDA(a) | $-942 | $-464 | $-430 | $-800 | $-366 |